C. Chen*a (Dr), Y. Songa (Prof), Y. Tanga (Mr), K. Zhaia (Mr)

a Department of Thoracic Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, CHINA

* 29217036@qq.com


Broncho pleural fistula is a serious complication of pulmonary resection refers to fistula formation between bronchial and pleural levels of all causes, pneumonectomy, lobectomy is particularly common. The emergence and development of interventional treatment technology provides new possibilities for the treatment of bronchial fistula. In this study, we reported six cases of atrial septal defect using occluder treatment of bronchial fistula clinic experience.

Case report

Six patients with bronchopleural fistula admitted to the Department of Thoracic Surgery of the Affiliated Hospital of Zunyi Medical University from January 2018 to December 2020, all patients with bronchopleural fistula after lobectomy. Underlying diseases: two cases of bronchial lung cancer and four cases of tuberculosis (one case was aspergilloma and three cases were destroyed lung). Operation sites: one case of left pneumonectomy, two cases of left upper pneumonectomy, two cases of right upper pneumonectomy, one case of right middle and lower pneumonectomy. Of which three males, three females, average age 62 years old. All patients underwent occlusion parties signed an informed consent form, were reported to the hospital ethics committee approval. Six patients, five were successfully inserted ASD occluder, one patient surgical failure. Five patients had successful surgery recovery was very satisfactory.


The atrial septal occluder is used to seal the bronchopleural fistula formed after lobectomy, and then the local cauterization of the mucosa around the occluder is applied to promote local granulation hyperplasia. This surgical method has good clinical effects and is worthy of popularization.

Disclosure of funding source(s): none